# About BPC-157 Medicinal — Editorial Standards and Publisher Information

> BPC-157 Medicinal is an independent editorial project that publishes summaries of the peer-reviewed research literature on Body Protection Compound 157. Not a clinic. Not affiliated with any vendor.

## What This Site Is

BPC-157 Medicinal is an independent editorial project that publishes summaries of the peer-reviewed research literature on Body Protection Compound 157 (BPC-157). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The domain modifier 'medicinal' reflects our editorial focus — the medicinal-research question: what does the scientific literature suggest about this compound's biological properties? It is not a claim that BPC-157 is approved for medicinal use (it is not, in any regulatory jurisdiction), nor that this site provides medical services of any kind.

All content on this site is sourced from peer-reviewed publications, preprints, and regulatory documents that are publicly accessible. Every quantitative claim is cited; every citation links to its primary source.

## Editorial Standards

**Source selection:** Only peer-reviewed journal articles, systematic reviews, and formal pharmacokinetic studies are cited. Conference presentations, unverified anecdotes, and community-sourced data are excluded. The three human pilot studies cited on this site (Lee & Padgett 2021, Lee et al. 2024, Lee & Burgess 2025) are the only published human data for BPC-157 as of this site's last content update; they are categorized as blue-coded evidence throughout the site to keep them visually distinct from the preclinical literature.

**Evidence categorization:** This site uses a four-color categorical system — green for mechanistically established multi-paper preclinical findings, amber for preclinical-only or single-group findings, red for regulatory and WADA caveats, blue for human pilot studies. This system encodes the strength and type of evidence into the visual structure of the dashboard, not just the prose.

**What this site does not do:** We do not recommend doses, regimens, routes of administration, or combinations of compounds. We do not assess whether BPC-157 is appropriate for any individual's research protocol. We do not provide clinical consultation, medical advice, or product referrals.

**Conflicts of interest:** BPC-157 Medicinal has no financial relationship with any peptide manufacturer, research chemical supplier, clinic, or telehealth provider. The site does not accept advertising, sponsorship, or affiliate compensation.

## Research Context Note

The term 'medicinal' in the domain name is editorial shorthand for 'medicinal-research literature.' BPC-157 is a research compound. It is classified as a WADA S0 prohibited substance — Non-Approved Substances — at all times. No regulatory agency in any jurisdiction has approved it for human use. No completed randomized controlled trials have been published. The preclinical evidence base is extensive and active (20+ findings cataloged here from 2003 through 2026), but the gap between preclinical activity and approved clinical use is large and not yet bridged by controlled human evidence.

This site exists to present that evidence base clearly — including its strengths (mechanistically characterized, multiple tissues, multiple species, consistent directional findings), its gaps (predominance of Zagreb-group authorship, limited independent replication, no RCTs, only three small human pilots), and its regulatory constraints (WADA prohibition, FDA non-approval, DoD banned list).

---

For research purposes only. Not for human consumption. This site does not sell any product and is not affiliated with any vendor.